Abstract:Objective:The present study aimed to investigate the expressions of P16,P15,and vascular endothelial growth factor(VEGF) in primary epithelial ovarian carcinoma as well as their relationship with clinicopathological features.Methods: P16,P15,and VEGF proteins were detected in 170 cases of primary epithelial ovarian carcinoma,60 cases of borderline tumors,and 60 cases of benign tumors by using S-P immunohistochemical staining method.Result: In ovarian carcinoma,the positive expression rate of P16 was 40.0%.This rate was lower than that in benign tumors(65.0%) and borderline tumors(56.7%;P<0.05).In epithelial ovarian carcinoma,the positive expression rate of P15 was 45.3%.This rate was also lower than that in benign tumors(68.3%) and borderline tumors(61.7%;P<0.05).In epithelial ovarian carcinoma,the positive expression rate of VEGF was 71.2%.This was higher than that in benign tumors(45.0%) and borderline tumors(53.3%;P<0.05).In ovarian carcinoma,P16 expression was positively correlated with P15(r=0.294;P<0.01),but VEGF expression was negatively correlated with P16 and P15(r=-0.461;r=-0.251;P<0.01).The expressions of these three proteins were significantly correlated with the degree of tumor differentiation,clinical stage,and lymph node metastasis.In lymph node metastasis,high clinical stage,or poor differentiation,low positive rates of P16 and P15 were observed(P<0.05).For VEGF,the positive rate was high.P16 and P15 expressions were not correlated with vascular invasion.VEGF expression was higher in the vascular invasion group than in the non-vascular invasion group.Conclusion: Low P16 and P15 expressions as well as high VEGF expression may exhibit synergistic effects on the development of ovarian carcinoma and simultaneously promote malignant development of ovarian carcinoma.

[Expression of AIB1 protein in epithelial ovarian cancer cells and its impact on apoptosis].

[Expression of AIB1 Protein in Gynecological Tumors].

A Study on the Expression and Clinical Significance of AIB1 Protein in Ovarian Borderline Epithelial Tumor

Correlation of expression of AIB1 protein with ER and PR in epithelial ovarian cancer

The Amplification and Protein Expression of AIB1 Gene and Its Clinical Significance in Ovarian Cancer

ABO Blood Groups and Expression of Blood Group Antigens of Epithelial Ovarian Cancer in Chinese Women.

Expression and clinical significance of P16, P15,and VEGF proteins in primary epithelial ovarian carcinoma

Expression of AIB1 Protein in Carcinoma of Endometrium

AIB1 expression in cervical cancer

Correlation of AIB1 Overexpression with Advanced Clinical Stage of Human Colorectal Carcinoma

[Expression and Clinical Significance of DNAJB11 in Epithelial Ovarian Cancer].

The Expression and Significance of BCL-2, BAX and P53 Proteins in Epithelial Ovarian Cancer

Correlation research of AIB1 expression and prognosis of breast cancer

Platelet-activating Factor Acetyl Hydrolase IB2 Dysregulated Cell Proliferation in Ovarian Cancer

AIB1 predicts bladder cancer outcome and promotes bladder cancer cell proliferation through AKT and E2F1

[Significance of Expression of THY1 Protein in Epithelial Ovarian Cancer].

AIB1 predicts tumor response to definitive chemoradiotherapy and prognosis in cervical squamous cell carcinoma.

The expression and clinical significance of amplified in breast cancer 1 protein in thyroid tumor tissues

The Role of AIB1 in Breast Cancer.

Overexpression of AIB1 Negatively Affects Survival of Surgically Resected Non-Small-cell Lung Cancer Patients.

Protein Expression and Amplification of AIB1 in Human Urothelial Carcinoma of the Bladder and Overexpression of AIB1 is a New Independent Prognostic Marker of Patient Survival